What break? Sarep­ta vet Ed Kaye quick­ly piv­ots to the helm of an­oth­er biotech up­start with a $40M bankroll

Af­ter Ed Kaye left the helm at Sarep­ta last Au­gust, he promised his wife he’d take some time off be­fore start­ing his next job in biotech.

Then the calls start­ed com­ing in.

“The phone rang off the hook,” says Kaye, a pop­u­lar fig­ure in the bustling Cam­bridge/Boston hub who has a re­sume that cov­ers every as­pect of biotech ex­is­tence. It’s the kind of back­ground that ven­ture groups love.

“With­in weeks I had 6 of­fers,” he says with­out even a slight trace of boast­ing. One fund he talked with “said that if we had 20 peo­ple like you, we’d start 20 com­pa­nies.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.